Book a Meeting

Anti-ganglioside GD3 Antibody, Non-Fucosylated (BioBet-447ZP)

Cat#: BioBet-447ZP
Target: ganglioside GD3
Isotype: IgG2b, κ
Host: Mouse
Species Reactivity: Human

Description Anti-ganglioside GD3 Antibody, Non-Fucosylated (BioBet-447ZP) is a mouse monoclonal IgG2b, κ antibody against ganglioside GD3. This product is an ADCC enhanced antibody produced by our Afuco™ platform.

Antibody Indication Melanoma

Classification Therapeutic antibody; biobetter

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced ganglioside GD3 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name ST8SIA1

Alternative Names mitumomab;216503-58-1;BEC-2;ST8SIA1;ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sialyltransferase 1;sialyltransferase 8 (alpha N acetylneuraminate: alpha 2, 8 sialytransferase, GD3 synthase) A , SIAT8, SIAT8A;alpha-N-acetylneuraminide alpha-2, 8-sialyltrans

Gene ID 6489

UniProt ID Q92185

Cellular Localization Golgi apparatus

Involvement in Disease Diseases associated with ST8SIA1 include Miller Fisher Syndrome.

Related Pathways Its related pathways are Transport to the Golgi and subsequent modification and Glycosphingolipid biosynthesis - ganglio series.

Function Involved in the production of gangliosides GD3 and GT3 from GM3; gangliosides are a subfamily of complex glycosphinglolipds that contain one or more residues of sialic acid.

Post-translational modifications 1.Glycosylation at Asn71, Asn119, Asn214, and Asn245 2.Modification sites at PhosphoSitePlus

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Isotype IgG2b, κ

Antibody Clone BioBet-447ZP

Description ADCC-enhanced mitumomab is a non-fucosylated anti-ganglioside GD3 therapeutic biobetter antibody.

Antibody Indication Melanoma

Melanoma

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas